Supplier News Breaks Archives

Week of Mon, Oct 17th, 2011

Watson to market lower-dose testosterone patch

Watson Pharmaceuticals Inc. has received approval from the Food and Drug Administration for 2-mg and 4-mg formulations of its Androderm testosterone transdermal system.

Authorized generic pact signed by Prasco, Eli Lilly

Prasco Laboratories has entering a marketing and distribution agreement with Eli Lilly and Co. to market an authorized generic version of Zyprexa tablets and Zyprexa Zydis orally disintegrating tablets in the United States.

Bayer category manager joins Emerson Group

The Emerson Group has hired Shane Brown to provide category management insight to its Walmart business team.

Abbott to split into two companies

Abbott has unveiled plans to separate into two publicly traded companies, one in diversified medical products and the other in research-based pharmaceuticals.

It's official: Matrix renamed Mylan Laboratories

Mylan Inc. announced that its India-based subsidiary, Matrix Laboratories Ltd., has formally changed its name to Mylan Laboratories Ltd.

Senior management changes at Bristol-Myers Squibb

Bristol-Myers Squibb Co. has announced some executive moves within its senior management team.

Scope Dual-Blast leads bad breath crusade

Appearing at food festivals nationwide this summer, Scope has rolled out its latest collection of products with its new Dual-Blast technology, which is designed to eliminate strong food odors like onion and garlic while killing bad breath germs.

Prasco to distribute Aspen branded drugs

Prasco Laboratories has been named the exclusive U.S. distributor and pharmaceutical services provider for Aspen Global branded prescription drugs.

Sandoz to add Falcon eye products from Alcon

The ophthalmic and otic products of Falcon Pharmaceuticals Ltd., the U.S. generics business of Alcon Inc., are being brought under the Sandoz umbrella.

Par Pharmaceutical picks up three Teva generics

Par Pharmaceutical Cos. has acquired rights to three products from Teva Pharmaceuticals in connection with Teva's acquisition of Cephalon.

Archimedes rolls out Lazanda

Archimedes Pharma Ltd. and its subsidiary, Archimedes Pharma U.S. Inc., have rolled out Lazanda fentanyl nasal spray to U.S. pharmacies.

Kirby Lester unveils Rx automation 'one-two punch'

Kirby Lester has introduced the Kirby Lester 60/30 Combination, a solution that the company bills as packing "a one-two pharmacy automation punch."

Lannett ships three new generics

Lannett Co. has launched a trio of new generic drug products recently approved by the Food and Drug Administration.

Teva wraps up Cephalon acquisition

Teva Pharmaceutical Industries Ltd. has closed its acquisition of Cephalon Inc.